An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Drug Acquiring Traction Via Social Media
Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to message these accounts directly for supplier links, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison images, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Express Worries
However, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the UK is worrisome and could lead to users administering products of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.
Platform Response and Material Removal
Based on the social media company, the platform has taken down violative content and prohibited related hashtags and search suggestions. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.
Digital Marketplace Operations
Investigations also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of weight loss, glowing testimonials and detailed guides for mixing or administering at residence.
After moments of entering one community, a seller shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.
Product Information and Costs
Within these communities, posts show black plastic packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how much time a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service stated it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has previously seen individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly serious medical dangers”.
